Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus

Theresa H. Nguyen, Nicole N. Haese, Nikhil Madadi, Sanjay Sarkar, Kiley Bonin, Cassilyn E. Streblow, Sharon Taft-Benz, Nichole A. Tower, Lynn Rasmussen, Robert Bostwick, Corinne E. Augelli-Szafran, Mark J. Suto, Thomas E. Morrison, Victor Defilippis, Mark T. Heise, Daniel N. Streblow, Ashish K. Pathak

Research output: Contribution to journalArticle

Abstract

Alphaviruses are arthropod-transmitted members of the Togaviridae family that can cause severe disease in humans, including debilitating arthralgia and severe neurological complications. Currently, there are no approved vaccines or antiviral therapies directed against the alphaviruses, and care is limited to treating disease symptoms. A phenotypic cell-based high-throughput screen was performed to identify small molecules that inhibit the replication of Venezuelan Equine Encephalitis Virus (VEEV). The compound, 1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-N-(3-fluoro-4-methoxybenzyl)ethan-1-amine (1), was identified as a highly active, potent inhibitor of VEEV with an effective concentration for 90% inhibition of virus (EC90) of 0.89 μM and 7.49 log reduction in virus titers at 10 μM concentration. These data suggest that further investigation of compound 1 as an antiviral therapeutic against VEEV, and perhaps other alphaviruses, is warranted. Experiments suggested that the antiviral activity of compound 1 is directed at an early step in the VEEV replication cycle by blocking viral RNA and protein synthesis.

Original languageEnglish (US)
JournalACS Infectious Diseases
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Venezuelan Equine Encephalitis Viruses
Alphavirus
Antiviral Agents
Togaviridae
Arthropods
Viral RNA
Arthralgia
Viral Proteins
Virus Replication
Viral Load
Amines
Vaccines
Viruses
dibenzylamine
Therapeutics

Keywords

  • alphaviruses
  • antiviral inhibitors
  • dibenzyl amines
  • VEEV

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Nguyen, T. H., Haese, N. N., Madadi, N., Sarkar, S., Bonin, K., Streblow, C. E., ... Pathak, A. K. (Accepted/In press). Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.9b00035

Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus. / Nguyen, Theresa H.; Haese, Nicole N.; Madadi, Nikhil; Sarkar, Sanjay; Bonin, Kiley; Streblow, Cassilyn E.; Taft-Benz, Sharon; Tower, Nichole A.; Rasmussen, Lynn; Bostwick, Robert; Augelli-Szafran, Corinne E.; Suto, Mark J.; Morrison, Thomas E.; Defilippis, Victor; Heise, Mark T.; Streblow, Daniel N.; Pathak, Ashish K.

In: ACS Infectious Diseases, 01.01.2019.

Research output: Contribution to journalArticle

Nguyen, TH, Haese, NN, Madadi, N, Sarkar, S, Bonin, K, Streblow, CE, Taft-Benz, S, Tower, NA, Rasmussen, L, Bostwick, R, Augelli-Szafran, CE, Suto, MJ, Morrison, TE, Defilippis, V, Heise, MT, Streblow, DN & Pathak, AK 2019, 'Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus', ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.9b00035
Nguyen, Theresa H. ; Haese, Nicole N. ; Madadi, Nikhil ; Sarkar, Sanjay ; Bonin, Kiley ; Streblow, Cassilyn E. ; Taft-Benz, Sharon ; Tower, Nichole A. ; Rasmussen, Lynn ; Bostwick, Robert ; Augelli-Szafran, Corinne E. ; Suto, Mark J. ; Morrison, Thomas E. ; Defilippis, Victor ; Heise, Mark T. ; Streblow, Daniel N. ; Pathak, Ashish K. / Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus. In: ACS Infectious Diseases. 2019.
@article{8123cdab475b4b84ace809bd97b16e6c,
title = "Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus",
abstract = "Alphaviruses are arthropod-transmitted members of the Togaviridae family that can cause severe disease in humans, including debilitating arthralgia and severe neurological complications. Currently, there are no approved vaccines or antiviral therapies directed against the alphaviruses, and care is limited to treating disease symptoms. A phenotypic cell-based high-throughput screen was performed to identify small molecules that inhibit the replication of Venezuelan Equine Encephalitis Virus (VEEV). The compound, 1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-N-(3-fluoro-4-methoxybenzyl)ethan-1-amine (1), was identified as a highly active, potent inhibitor of VEEV with an effective concentration for 90{\%} inhibition of virus (EC90) of 0.89 μM and 7.49 log reduction in virus titers at 10 μM concentration. These data suggest that further investigation of compound 1 as an antiviral therapeutic against VEEV, and perhaps other alphaviruses, is warranted. Experiments suggested that the antiviral activity of compound 1 is directed at an early step in the VEEV replication cycle by blocking viral RNA and protein synthesis.",
keywords = "alphaviruses, antiviral inhibitors, dibenzyl amines, VEEV",
author = "Nguyen, {Theresa H.} and Haese, {Nicole N.} and Nikhil Madadi and Sanjay Sarkar and Kiley Bonin and Streblow, {Cassilyn E.} and Sharon Taft-Benz and Tower, {Nichole A.} and Lynn Rasmussen and Robert Bostwick and Augelli-Szafran, {Corinne E.} and Suto, {Mark J.} and Morrison, {Thomas E.} and Victor Defilippis and Heise, {Mark T.} and Streblow, {Daniel N.} and Pathak, {Ashish K.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1021/acsinfecdis.9b00035",
language = "English (US)",
journal = "ACS Infectious Diseases",
issn = "2373-8227",
publisher = "American Chemical Society",

}

TY - JOUR

T1 - Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus

AU - Nguyen, Theresa H.

AU - Haese, Nicole N.

AU - Madadi, Nikhil

AU - Sarkar, Sanjay

AU - Bonin, Kiley

AU - Streblow, Cassilyn E.

AU - Taft-Benz, Sharon

AU - Tower, Nichole A.

AU - Rasmussen, Lynn

AU - Bostwick, Robert

AU - Augelli-Szafran, Corinne E.

AU - Suto, Mark J.

AU - Morrison, Thomas E.

AU - Defilippis, Victor

AU - Heise, Mark T.

AU - Streblow, Daniel N.

AU - Pathak, Ashish K.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Alphaviruses are arthropod-transmitted members of the Togaviridae family that can cause severe disease in humans, including debilitating arthralgia and severe neurological complications. Currently, there are no approved vaccines or antiviral therapies directed against the alphaviruses, and care is limited to treating disease symptoms. A phenotypic cell-based high-throughput screen was performed to identify small molecules that inhibit the replication of Venezuelan Equine Encephalitis Virus (VEEV). The compound, 1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-N-(3-fluoro-4-methoxybenzyl)ethan-1-amine (1), was identified as a highly active, potent inhibitor of VEEV with an effective concentration for 90% inhibition of virus (EC90) of 0.89 μM and 7.49 log reduction in virus titers at 10 μM concentration. These data suggest that further investigation of compound 1 as an antiviral therapeutic against VEEV, and perhaps other alphaviruses, is warranted. Experiments suggested that the antiviral activity of compound 1 is directed at an early step in the VEEV replication cycle by blocking viral RNA and protein synthesis.

AB - Alphaviruses are arthropod-transmitted members of the Togaviridae family that can cause severe disease in humans, including debilitating arthralgia and severe neurological complications. Currently, there are no approved vaccines or antiviral therapies directed against the alphaviruses, and care is limited to treating disease symptoms. A phenotypic cell-based high-throughput screen was performed to identify small molecules that inhibit the replication of Venezuelan Equine Encephalitis Virus (VEEV). The compound, 1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-N-(3-fluoro-4-methoxybenzyl)ethan-1-amine (1), was identified as a highly active, potent inhibitor of VEEV with an effective concentration for 90% inhibition of virus (EC90) of 0.89 μM and 7.49 log reduction in virus titers at 10 μM concentration. These data suggest that further investigation of compound 1 as an antiviral therapeutic against VEEV, and perhaps other alphaviruses, is warranted. Experiments suggested that the antiviral activity of compound 1 is directed at an early step in the VEEV replication cycle by blocking viral RNA and protein synthesis.

KW - alphaviruses

KW - antiviral inhibitors

KW - dibenzyl amines

KW - VEEV

UR - http://www.scopus.com/inward/record.url?scp=85073159452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073159452&partnerID=8YFLogxK

U2 - 10.1021/acsinfecdis.9b00035

DO - 10.1021/acsinfecdis.9b00035

M3 - Article

C2 - 31257853

AN - SCOPUS:85073159452

JO - ACS Infectious Diseases

JF - ACS Infectious Diseases

SN - 2373-8227

ER -